CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 177 enrolled
Drug / intervention
Boston Scientific WaveWriter SCS Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04618471
NCT04618471N/AActive
CompareCT.gov

Study to Demonstrate the Value of Paresthesia-Free Fast-Acting Subperception (FAST) and Other SCS Therapies Using WaveWriter™ Spinal Cord Stimulator Systems in the Treatment of Chronic Pain

Boston Scientific Corporation·interventional·Posted Nov 6, 2020·Updated Jun 11, 2026

In Brief

A clinical study evaluating Boston Scientific WaveWriter SCS System for Chronic Pain. Active but no longer recruiting, targeting 177 participants across 13 sites.

Detailed Summary

Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain
CountriesUnited States
Collaborators--

Timeline

N/AActive
202120222023202420252026202720282029
First PostedNov 6, 2020
Enrollment StartFeb 10, 2021
Primary CompletionDec 14, 2022
Study CompletionMar 1, 2029
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.7 years ago

Interventions

Boston Scientific WaveWriter SCS Systemdevice

WaveWriter SCS Programming